366 studies found for:    dialysis [CONDITION] OR dialysis [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Conditions: Functionally Anuric;   Hemodialysis/Peritoneal Dialysis
Intervention: Other: Adjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis
2 Recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
3 Recruiting Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
4 Not yet recruiting Virtual Ward for Home Dialysis
Conditions: End Stage Renal Disease;   Kidney Failure;   Home Dialysis
Interventions: Other: Telephone follow-up;   Other: Sympton Assessment
5 Recruiting Prevention of Peritonitis in Peritoneal Dialysis
Conditions: Kidney Failure, Chronic;   Peritoneal Dialysis-associated Peritonitis;   Dialysis Capd Infection
Intervention: Behavioral: Follow-up of PD patients´ theoretical and practical skills
6 Recruiting An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Conditions: Healthy Subjects;   Cytomegalovirus Infection;   Dialysis
Interventions: Drug: ASP0113;   Drug: Placebo
7 Not yet recruiting Improving Outcomes in Peritoneal Dialysis
Conditions: Chronic Kidney Disease;   Peritoneal Dialysis Access
Intervention:
8 Unknown  Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments
Condition: Cardiovascular Disease
Intervention: Procedure: dialysis
9 Unknown  Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
10 Unknown  A Study to Evaluate the Effects of Icodextrin Versus 2.5% Dianeal on Insulin Resistance in Non Diabetic Apd Patients
Condition: Disorders Associated With Peritoneal Dialysis
Interventions: Other: icodextrin;   Other: Dianeal
11 Not yet recruiting Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients
Conditions: Hemodialysis, Home;   Peritoneal Dialysis
Intervention: Other: Electronic Patient Portal
12 Recruiting Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis
Conditions: End-stage Renal Disease (ESRD);   Kidney Disease
Interventions: Other: DIANEAL;   Other: EXTRANEAL
13 Unknown  The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
14 Recruiting Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
Condition: Chronic Kidney Failure
Intervention: Drug: Solution for Peritoneal Dialysis
15 Recruiting A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
Conditions: End Stage Renal Failure on Dialysis;   Complication of Dialysis;   Blood Coagulation Disorders
Intervention:
16 Recruiting Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis
Condition: Peritoneal Dialysis Associated Peritonitis
Intervention: Other: endotoxin assay in peritoneal dialysis effluent
17 Unknown  Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
Conditions: Renal Failure, End Stage;   Peritoneal Dialysis
Intervention: Drug: Simvastatin
18 Recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Conditions: Peritoneal Dialysis;   Wasting and Malnutrition
Intervention:
19 Unknown  Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients
Condition: End-Stage Renal Disease
Interventions: Drug: 6 L dialysate;   Drug: 8 L dialysate
20 Unknown  Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years